The ERBB3 receptor in cancer and cancer gene therapy.

Cancer Gene Therapy
G Sithanandam, L M Anderson

Abstract

ERBB3, a member of the epidermal growth factor receptor (EGFR) family, is unique in that its tyrosine kinase domain is functionally defective. It is activated by neuregulins, by other ERBB and nonERBB receptors as well as by other kinases, and by novel mechanisms. Downstream it interacts prominently with the phosphoinositol 3-kinase/AKT survival/mitogenic pathway, but also with GRB, SHC, SRC, ABL, rasGAP, SYK and the transcription regulator EBP1. There are likely important but poorly understood roles for nuclear localization and for secreted isoforms. Studies of ERBB3 expression in primary cancers and of its mechanistic contributions in cultured cells have implicated it, with varying degrees of certainty, with causation or sustenance of cancers of the breast, ovary, prostate, certain brain cells, retina, melanocytes, colon, pancreas, stomach, oral cavity and lung. Recent results link high ERBB3 activity with escape from therapy targeting other ERBBs in lung and breast cancers. Thus a wide and centrally important role for ERBB3 in cancer is becoming increasingly apparent. Several approaches for targeting ERBB3 in cancers have been tested or proposed. Small inhibitory RNA (siRNA) to ERBB3 or AKT is showing promise as a therapeuti...Continue Reading

References

Dec 1, 1992·British Journal of Cancer·N R LemoineH C Hurst
Nov 1, 1992·The Journal of Pathology·N R LemoineG Klöppel
Sep 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·F CiardielloD S Salomon
Jul 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·G D PlowmanM Shoyab
Dec 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M H KrausS A Aaronson
Jun 1, 1994·Molecular and Cellular Biology·S P SoltoffL C Cantley
Nov 3, 1995·The Journal of Biological Chemistry·H I SwansonC A Bradfield
Jun 22, 1995·International Journal of Cancer. Journal International Du Cancer·B J SimpsonW R Miller
Jun 1, 1995·The Journal of Steroid Biochemistry and Molecular Biology·P LimontaM Motta
May 14, 1993·Biochemical and Biophysical Research Communications·M KatohM Terada
Apr 1, 1995·British Journal of Cancer·B J SimpsonW R Miller
Aug 3, 1994·Journal of the National Cancer Institute·R B MyersW E Grizzle
Jul 25, 1994·FEBS Letters·Y A KitaM Nicolson
Aug 16, 1994·Proceedings of the National Academy of Sciences of the United States of America·P M GuyK L Carraway
Jul 30, 1993·International Journal of Cancer. Journal International Du Cancer·E E SanidasD A Levison
Mar 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·G D PlowmanM Shoyab
Mar 1, 1996·The Journal of Biological Chemistry·J BaulidaG Carpenter
Feb 16, 1996·The Journal of Biological Chemistry·J B LyczakS L Morrison
Feb 16, 1996·The Journal of Biological Chemistry·K ZhangS K Yoshinaga
Jun 11, 1996·Proceedings of the National Academy of Sciences of the United States of America·D RobinsonH J Kung
Jun 7, 1996·The Journal of Biological Chemistry·R S CarverW E Russell
Aug 2, 1996·The Journal of Biological Chemistry·M VecchiG Carpenter
Sep 4, 1996·Biochemical and Biophysical Research Communications·Y KitaM Nicolson
May 2, 1997·The Journal of Biological Chemistry·D C GamettI Friedberg
Nov 20, 1997·Journal of Cellular Physiology·F U WeissA Ullrich

❮ Previous
Next ❯

Citations

Mar 5, 2013·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Alexandre Andrade Anjos JácomeJosé Sebastião Santos
May 16, 2013·Proceedings of the National Academy of Sciences of the United States of America·John HinesCraig M Crews
Jul 19, 2012·Biochemistry. Biokhimii︠a︡·O L PolanovskiS M Deyev
Apr 2, 2011·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Luke Truitt, Andrew Freywald
Jan 22, 2011·Sarcoma·Lisa E S Crose, Corinne M Linardic
Dec 1, 2012·Chemotherapy Research and Practice·Ning JiangZhuo Georgia Chen
Apr 2, 2013·The Journal of Clinical Investigation·Ethan V AbelAndrew E Aplin
Sep 15, 2011·PloS One·Carla Lucia EspositoLaura Cerchia
Apr 15, 2014·PloS One·Trine Ostergaard NielsenBoe Sandahl Sorensen
Nov 1, 2012·World Journal of Gastroenterology : WJG·Jae Yun LimJae Yong Cho
Nov 9, 2012·International Journal of Oncology·Megumi NozatoHiroaki Komuro
Sep 10, 2014·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Liying WangYu Han
Sep 10, 2013·Virchows Archiv : an International Journal of Pathology·Guido BellezzaAngelo Sidoni
Jul 29, 2009·World Journal of Surgery·Xiu Li ZhangJin Huang
Nov 26, 2009·Journal of Cancer Research and Clinical Oncology·Xu ZhouYoucheng Yu
May 31, 2012·Drug Delivery·Ravikumar AalinkeelStanley A Schwartz
Jan 26, 2010·Expert Opinion on Investigational Drugs·Muhammad W Saif
Feb 6, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Kuan CaoRenhao Wang
Feb 3, 2016·Head & Neck·Bénédicte RysmanSamuel Meignan
Oct 18, 2011·Artificial Intelligence in Medicine·Thanh-Phuong Nguyen, Tu-Bao Ho
Oct 27, 2015·Acta Biochimica Et Biophysica Sinica·Ningyan ZhangZhiqiang An
Nov 11, 2008·Experimental Cell Research·Karl R Schmitz, Kathryn M Ferguson
May 27, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Hongyan LiuZhijun Zhang
Apr 13, 2011·International Journal of Cancer. Journal International Du Cancer·Eric TrocméYingbo Lin

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.